524
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Oncolytic Viruses: Cytolytic agents, Replicating Immunotherapeutics Or both?

, , &
Pages 445-448 | Received 17 Mar 2018, Accepted 19 Apr 2018, Published online: 12 Jun 2018
 

Financial & competing interests disclosure

JC Bell is a founder and sits on the Board of Directors for Turnstone Biologics. JCB is supported by the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society Research Institute, the Ontario Institute of Cancer Research, and the Terry Fox Foundation. ATC is supported by a CIHR Master’s Award. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.